GentiBio

Updated: October 31, 2025

CEO - Andy Walker

Country: USA | Funding: $177M (+)

Website: http://www.gentibio.com/

GentiBio is a biotherapeutics company developing engineered regulatory T cells (EngTregs) programmed to treat autoimmune allergic diseases.

Competitors